Covered Call Analyzer from Investment Enhancing Systems, Inc.

The Covered Call Analyzer

$10,000 Monitored Aggressive Portfolio Trades fo September 19, 2009

This is a rolling portfolio and we will look at open positions and make new trades using monies from called and sold positions each month on expiration weekend. The statements starting "Buy...." is what the Covered Call Analyzer tells you to do after finding the best buy/writes and calculating the values.
Close Window

Call Premium Cost Balance

From August: $905

From Aggressive "Stocks-to-Consider" July 18, 2009 and putting $2,000 in the money available field

Buy 100 shares of SAVIENT PHARMACEUTICALS (SVNT) at $14.43 (closing last trade price) and sell 1 call Out-of-the-Money contracts of UVP HC (Aug$15.00) at $1.45 (closing bid price) expiring on 8/22/2009. Cost is $1,453, and income from sale of the calls is $134 and includes your commissions. Annualized return if called is 130%. Not called on August 22. Will now sell Sep15 at $0.50. Price at $13.71 and value at $1,533, up 5.5% on August 22 including sale of all calls. Called on September 19 at $15.00. Proceeds $1,490 after commission. Total return including call premium is $1,662, up 14.4%.
$2,395

From Aggressive "Stocks-to-Consider" August 22, 2009 and putting $2,000 in the money available field

Buy 100 shares of OSIRIS THERAPEUTICS INC (OSIR) at $12.25 (closing last trade price) and sell 1 call Out-of-the-Money contracts of QIU IV (Sep$12.50) at $3.50 (closing bid price) expiring on 9/19/2009. Cost is $1,235, and income from sale of the calls is $339 and includes your commissions. Annualized return if called is 374%.Stock tanked on September 8 on bad news. Held stock for five trading days anticipating bounce and then held for three more days so the calls didn't have to be bought back. Sold all shares at $7.97 on September 19 to close out position. Proceeds $787 after commission. Final value including sale of all calls is $1,119, down (9.4%).
$3,182

Buy 200 shares of VIVUS INC (VVUS) at $6.78 (closing last trade price) and sell 2 call Out-of-the-Money contracts of QJS IU (Sep$7.50) at $0.70 (closing bid price) expiring on 9/19/2009. Cost is $1,366, and income from sale of the calls is $127 and includes your commissions. Annualized return if called is 249%. Called on September 19 at $7.50. Proceeds $1,490 after commission. Total return including call premium is $1,617, up 18.4%.
$4,672

Buy 100 shares of HURON CONSULTING GROUP (HURN) at $19.00 (closing last trade price) and sell 1 call Out-of-the-Money contracts of QWX ID (Sep$20.00) at $1.20 (closing bid price) expiring on 9/19/2009. Cost is $1,910, and income from sale of the calls is $109 and includes your commissions. Annualized return if called is 136%. Called on September 19 at $20.00. Proceeds $1,990 after commission. Total return including call premium is $2,099, up 9.9%.
$6,662

Buy 200 shares of BRUNSWICK CORP (BC) at $9.59 (closing last trade price) and sell 2 call Out-of-the-Money contracts of BC IB (Sep$10.00) at $0.65 (closing bid price) expiring on 9/19/2009. Cost is $1,928, and income from sale of the calls is $117 and includes your commissions. Annualized return if called is 128%. Not called on September 19. Price at $9.78 and value at $2,073, up 7.5% on September 19including sale of all calls. Sold all shares at $9.78 to close out position on September 19. Proceeds $1,946 after commission.
$8,608

Buy 200 shares of MOMENTA PHARMACEUTICALS (MNTA) at $9.74 (closing last trade price) and sell 2 call Out-of-the-Money contracts of QMP IB (Sep$10.00) at $0.65 (closing bid price) expiring on 9/19/2009. Cost is $1,958, and income from sale of the calls is $117 and includes your commissions. Annualized return if called is 106%. Called on September 19 at $10.00. Proceeds $1,990 after commission. Total return including call premium is $2,107, up 7.6%.
$10,598

Buy 200 shares of MCMORAN EXPLORATION CO (MMR) at $8.28 (closing last trade price) and sell 2 call Out-of-the-Money contracts of MMR IB (Sep$10.00) at $0.25 (closing bid price) expiring on 9/19/2009. Cost is $1,666, and income from sale of the calls is $37 and includes your commissions. Annualized return if called is 290%. Not called on September 19. Will now sell Oct10 at $0.25. Price at $8.61 and value at $1,796, up 7.8% on September 19 including sale of all calls.
$37 $10,635

Buy 100 shares of TAKE-TWO INTERA SOFTWARE (TTWO) at $10.29 (closing last trade price) and sell 1 call Out-of-the-Money contracts of TUO IV (Sep$12.50) at $0.30 (closing bid price) expiring on 9/19/2009. Cost is $1,039, and income from sale of the calls is $19 and includes your commissions. Annualized return if called is 289%. Not called on September 19. Will now sell Oct12.5 at $0.45. Price at $11.73 and value at $1,222, 17.6% on September 19 including sale of all calls.
$33 $10,668

Buy 100 shares of CANADIAN SOLAR INC (CSIQ) at $15.98 (closing last trade price) and sell 1 call Out-of-the-Money contracts of GQA IW (Sep$17.50) at $0.85 (closing bid price) expiring on 9/19/2009. Cost is $1,608, and income from sale of the calls is $74 and includes your commissions. Annualized return if called is 175%. Called on September 19 at $17.50. Proceeds $1,740 after commission. Total return including call premium is $1,814, up 12.8%.
$12,408

Buy 100 shares of AMYLIN PHARMACEUTICALS (AMLN) at $13.48 (closing last trade price) and sell 1 call Out-of-the-Money contracts of AQM IC (Sep$15.00) at $0.25 (closing bid price) expiring on 9/19/2009. Cost is $1,358, and income from sale of the calls is $14 and includes your commissions. Annualized return if called is 150%. Not called on September 19. Will now sell Oct15 at $0.30. Price at $13.10 and value at $1,342, down (1.2%) on September 19including sale of all calls.
$18 $12,426

Buy 100 shares of SAVIENT PHARMACEUTICALS (SVNT) at $13.71 (closing last trade price) and sell 1 call Out-of-the-Money contracts of UVP IC (Sep$15.00) at $0.40 (closing bid price) expiring on 9/19/2009. Cost is $1,381, and income from sale of the calls is $29 and includes your commissions. Annualized return if called is 140%. Called on September 19 at $15.00. Proceeds $1,490 after commission. Total return including call premium is $1,662, up 14.4%.
$13,916

From Aggressive "Stocks-to-Consider" September 19, 2009 and putting $2,000 in the money available field

Buy 100 shares of VANDA PHARMACEUTICALS (VNDA) at $12.59 (closing last trade price) and sell 1 call Out-of-the-Money contracts of QDX JC (Oct$15.00) at $1.15 (closing bid price) expiring on 10/17/2009. Cost is $1,269, and income from sale of the calls is $104 and includes your commissions. Annualized return if called is 320%
$104 $1,279 $12,741

Buy 300 shares of ONCOTHYREON INC (ONTY) at $6.34 (closing last trade price) and sell 3 call Out-of-the-Money contracts of KKQ JU (Oct$7.50) at $0.40 (closing bid price) expiring on 10/17/2009. Cost is $1,912, and income from sale of the calls is $106 and includes your commissions. Annualized return if called is 284%.
$106 $1,912 $10,935

Buy 200 shares of SINOVAC BIOTECH LTD (SVA) at $8.88 (closing last trade price) and sell 2 call Out-of-the-Money contracts of SVA JB (Oct$10.00) at $0.75 (closing bid price) expiring on 10/17/2009. Cost is $1,786, and income from sale of the calls is $137 and includes your commissions. Annualized return if called is 239%.
$137 $1,786 $9,286

Buy 200 shares of PONIARD PHARMACEUTICALS (PARD) at $7.06 (closing last trade price) and sell 2 call Out-of-the-Money contracts of FQR JU (Oct$7.50) at $1.05 (closing bid price) expiring on 10/17/2009. Cost is $1,422, and income from sale of the calls is $197 and includes your commissions. Annualized return if called is 233%.
$197 $1,422 $8,061

Buy 200 shares of SPECTRUM PHARMACEUTICALS (SPPI) at $7.18 (closing last trade price) and sell 2 call Out-of-the-Money contracts of QBV JU (Oct$7.50) at $0.80 (closing bid price) expiring on 10/17/2009. Cost is $1,446, and income from sale of the calls is $147 and includes your commissions. Annualized return if called is 165%.
$147 $1,446 $6,762

Buy 200 shares of ZALE CORP (ZLC) at $7.16 (closing last trade price) and sell 2 call Out-of-the-Money contracts of ZLC JU (Oct$7.50) at $0.75 (closing bid price) expiring on 10/17/2009. Cost is $1,442, and income from sale of the calls is $137 and includes your commissions. Annualized return if called is 160%.
$137 $1,442 $5,457

Buy 200 shares of JAZZ PHARMACEUTICALS INC (JAZZ) at $9.50 (closing last trade price) and sell 2 call Out-of-the-Money contracts of JWQ JB (Oct$10.00) at $0.80 (closing bid price) expiring on 10/17/2009. Cost is $1,910, and income from sale of the calls is $147 and includes your commissions. Annualized return if called is 149%.
$147 $1,910 $3,694

Buy 300 shares of MATRIXX INITIATIVES INC (MTXX) at $5.72 (closing last trade price) and sell 3 call Out-of-the-Money contracts of IHU JU (Oct$7.50) at $0.35 (closing bid price) expiring on 10/17/2009. Cost is $1,726, and income from sale of the calls is $91 and includes your commissions. Annualized return if called is 439%.
$91 $1,726 $2,059

Buy 200 shares of MGIC INVESTMENTS CORP (MTG) at $8.76 (closing last trade price) and sell 2 call Out-of-the-Money contracts of MTG JB (Oct$10.00) at $0.55 (closing bid price) expiring on 10/17/2009. Cost is $1,762, and income from sale of the calls is $97 and includes your commissions. Annualized return if called is 231%.
$97 $1,762 $394

Totals for September:
$1,251 $14,765 $394

Portfolio value at September 19 is $19,012*, up +90.1%. The NASDAQ average for the year so far is up +39.5%

*After the effect of all commissions.

The stocks listed above are for illustrative and educational purposes only and should not be construed as an endorsement, recommendation, or solicitation to buy or sell any particular security.

On January 17, 2009 (expiration weekend), Investment Enhancing Systems, Inc. initiated a new $10,000 aggressive portfolio for 2009, This portfolio uses stocks identified in our Aggressive "Stocks-to-Consider" list by selecting buy/writes from the "Stocks with high or negative PE ratios" list. We have set the money available to $2,000 and have reduced the commissions for purchasing the stock to $9.95 and selling the calls to $9.95 plus $1.50 per contract in our parameters page. Several low cost, on-line brokers offer these low commissions. Since it is an aggressive portfolio, we keep the premium income and stock price appreciation to the strike price in the portfolio. We update the portfolio each month on expiration weekend. Our objective is to maintain and grow the portfolio. The table above lists details of stocks bought and calls sold, and when we held the stock and sold more calls or exercised our get-out price. Note: In all of our lists and portfolios, we have established a get-out price which we exercise when the stock price drops 15%. If this happens during the month, we will get-out and report the sale of the stock and the buy-back of the calls at the next expiration weekend postings. We anticipate good months and poor months, with a general gain at year end. Patience usually wins.

	Call Premium	Cost	Balance
From August:			$905
From Aggressive "Stocks-to-Consider" July 18, 2009 and putting $2,000 in the money available field
Buy 100 shares of SAVIENT PHARMACEUTICALS (SVNT) at $14.43 (closing last trade price) and sell 1 call Out-of-the-Money contracts of UVP HC (Aug$15.00) at $1.45 (closing bid price) expiring on 8/22/2009. Cost is $1,453, and income from sale of the calls is $134 and includes your commissions. Annualized return if called is 130%. Not called on August 22. Will now sell Sep15 at $0.50. Price at $13.71 and value at $1,533, up 5.5% on August 22 including sale of all calls. Called on September 19 at $15.00. Proceeds $1,490 after commission. Total return including call premium is $1,662, up 14.4%.			$2,395
From Aggressive "Stocks-to-Consider" August 22, 2009 and putting $2,000 in the money available field
Buy 100 shares of OSIRIS THERAPEUTICS INC (OSIR) at $12.25 (closing last trade price) and sell 1 call Out-of-the-Money contracts of QIU IV (Sep$12.50) at $3.50 (closing bid price) expiring on 9/19/2009. Cost is $1,235, and income from sale of the calls is $339 and includes your commissions. Annualized return if called is 374%.Stock tanked on September 8 on bad news. Held stock for five trading days anticipating bounce and then held for three more days so the calls didn't have to be bought back. Sold all shares at $7.97 on September 19 to close out position. Proceeds $787 after commission. Final value including sale of all calls is $1,119, down (9.4%).			$3,182
Buy 200 shares of VIVUS INC (VVUS) at $6.78 (closing last trade price) and sell 2 call Out-of-the-Money contracts of QJS IU (Sep$7.50) at $0.70 (closing bid price) expiring on 9/19/2009. Cost is $1,366, and income from sale of the calls is $127 and includes your commissions. Annualized return if called is 249%. Called on September 19 at $7.50. Proceeds $1,490 after commission. Total return including call premium is $1,617, up 18.4%.			$4,672
Buy 100 shares of HURON CONSULTING GROUP (HURN) at $19.00 (closing last trade price) and sell 1 call Out-of-the-Money contracts of QWX ID (Sep$20.00) at $1.20 (closing bid price) expiring on 9/19/2009. Cost is $1,910, and income from sale of the calls is $109 and includes your commissions. Annualized return if called is 136%. Called on September 19 at $20.00. Proceeds $1,990 after commission. Total return including call premium is $2,099, up 9.9%.			$6,662
Buy 200 shares of BRUNSWICK CORP (BC) at $9.59 (closing last trade price) and sell 2 call Out-of-the-Money contracts of BC IB (Sep$10.00) at $0.65 (closing bid price) expiring on 9/19/2009. Cost is $1,928, and income from sale of the calls is $117 and includes your commissions. Annualized return if called is 128%. Not called on September 19. Price at $9.78 and value at $2,073, up 7.5% on September 19including sale of all calls. Sold all shares at $9.78 to close out position on September 19. Proceeds $1,946 after commission.			$8,608
Buy 200 shares of MOMENTA PHARMACEUTICALS (MNTA) at $9.74 (closing last trade price) and sell 2 call Out-of-the-Money contracts of QMP IB (Sep$10.00) at $0.65 (closing bid price) expiring on 9/19/2009. Cost is $1,958, and income from sale of the calls is $117 and includes your commissions. Annualized return if called is 106%. Called on September 19 at $10.00. Proceeds $1,990 after commission. Total return including call premium is $2,107, up 7.6%.			$10,598
Buy 200 shares of MCMORAN EXPLORATION CO (MMR) at $8.28 (closing last trade price) and sell 2 call Out-of-the-Money contracts of MMR IB (Sep$10.00) at $0.25 (closing bid price) expiring on 9/19/2009. Cost is $1,666, and income from sale of the calls is $37 and includes your commissions. Annualized return if called is 290%. Not called on September 19. Will now sell Oct10 at $0.25. Price at $8.61 and value at $1,796, up 7.8% on September 19 including sale of all calls.	$37		$10,635
Buy 100 shares of TAKE-TWO INTERA SOFTWARE (TTWO) at $10.29 (closing last trade price) and sell 1 call Out-of-the-Money contracts of TUO IV (Sep$12.50) at $0.30 (closing bid price) expiring on 9/19/2009. Cost is $1,039, and income from sale of the calls is $19 and includes your commissions. Annualized return if called is 289%. Not called on September 19. Will now sell Oct12.5 at $0.45. Price at $11.73 and value at $1,222, 17.6% on September 19 including sale of all calls.	$33		$10,668
Buy 100 shares of CANADIAN SOLAR INC (CSIQ) at $15.98 (closing last trade price) and sell 1 call Out-of-the-Money contracts of GQA IW (Sep$17.50) at $0.85 (closing bid price) expiring on 9/19/2009. Cost is $1,608, and income from sale of the calls is $74 and includes your commissions. Annualized return if called is 175%. Called on September 19 at $17.50. Proceeds $1,740 after commission. Total return including call premium is $1,814, up 12.8%.			$12,408
Buy 100 shares of AMYLIN PHARMACEUTICALS (AMLN) at $13.48 (closing last trade price) and sell 1 call Out-of-the-Money contracts of AQM IC (Sep$15.00) at $0.25 (closing bid price) expiring on 9/19/2009. Cost is $1,358, and income from sale of the calls is $14 and includes your commissions. Annualized return if called is 150%. Not called on September 19. Will now sell Oct15 at $0.30. Price at $13.10 and value at $1,342, down (1.2%) on September 19including sale of all calls.	$18		$12,426
Buy 100 shares of SAVIENT PHARMACEUTICALS (SVNT) at $13.71 (closing last trade price) and sell 1 call Out-of-the-Money contracts of UVP IC (Sep$15.00) at $0.40 (closing bid price) expiring on 9/19/2009. Cost is $1,381, and income from sale of the calls is $29 and includes your commissions. Annualized return if called is 140%. Called on September 19 at $15.00. Proceeds $1,490 after commission. Total return including call premium is $1,662, up 14.4%.			$13,916
From Aggressive "Stocks-to-Consider" September 19, 2009 and putting $2,000 in the money available field
Buy 100 shares of VANDA PHARMACEUTICALS (VNDA) at $12.59 (closing last trade price) and sell 1 call Out-of-the-Money contracts of QDX JC (Oct$15.00) at $1.15 (closing bid price) expiring on 10/17/2009. Cost is $1,269, and income from sale of the calls is $104 and includes your commissions. Annualized return if called is 320%	$104	$1,279	$12,741
Buy 300 shares of ONCOTHYREON INC (ONTY) at $6.34 (closing last trade price) and sell 3 call Out-of-the-Money contracts of KKQ JU (Oct$7.50) at $0.40 (closing bid price) expiring on 10/17/2009. Cost is $1,912, and income from sale of the calls is $106 and includes your commissions. Annualized return if called is 284%.	$106	$1,912	$10,935
Buy 200 shares of SINOVAC BIOTECH LTD (SVA) at $8.88 (closing last trade price) and sell 2 call Out-of-the-Money contracts of SVA JB (Oct$10.00) at $0.75 (closing bid price) expiring on 10/17/2009. Cost is $1,786, and income from sale of the calls is $137 and includes your commissions. Annualized return if called is 239%.	$137	$1,786	$9,286
Buy 200 shares of PONIARD PHARMACEUTICALS (PARD) at $7.06 (closing last trade price) and sell 2 call Out-of-the-Money contracts of FQR JU (Oct$7.50) at $1.05 (closing bid price) expiring on 10/17/2009. Cost is $1,422, and income from sale of the calls is $197 and includes your commissions. Annualized return if called is 233%.	$197	$1,422	$8,061
Buy 200 shares of SPECTRUM PHARMACEUTICALS (SPPI) at $7.18 (closing last trade price) and sell 2 call Out-of-the-Money contracts of QBV JU (Oct$7.50) at $0.80 (closing bid price) expiring on 10/17/2009. Cost is $1,446, and income from sale of the calls is $147 and includes your commissions. Annualized return if called is 165%.	$147	$1,446	$6,762
Buy 200 shares of ZALE CORP (ZLC) at $7.16 (closing last trade price) and sell 2 call Out-of-the-Money contracts of ZLC JU (Oct$7.50) at $0.75 (closing bid price) expiring on 10/17/2009. Cost is $1,442, and income from sale of the calls is $137 and includes your commissions. Annualized return if called is 160%.	$137	$1,442	$5,457
Buy 200 shares of JAZZ PHARMACEUTICALS INC (JAZZ) at $9.50 (closing last trade price) and sell 2 call Out-of-the-Money contracts of JWQ JB (Oct$10.00) at $0.80 (closing bid price) expiring on 10/17/2009. Cost is $1,910, and income from sale of the calls is $147 and includes your commissions. Annualized return if called is 149%.	$147	$1,910	$3,694
Buy 300 shares of MATRIXX INITIATIVES INC (MTXX) at $5.72 (closing last trade price) and sell 3 call Out-of-the-Money contracts of IHU JU (Oct$7.50) at $0.35 (closing bid price) expiring on 10/17/2009. Cost is $1,726, and income from sale of the calls is $91 and includes your commissions. Annualized return if called is 439%.	$91	$1,726	$2,059
Buy 200 shares of MGIC INVESTMENTS CORP (MTG) at $8.76 (closing last trade price) and sell 2 call Out-of-the-Money contracts of MTG JB (Oct$10.00) at $0.55 (closing bid price) expiring on 10/17/2009. Cost is $1,762, and income from sale of the calls is $97 and includes your commissions. Annualized return if called is 231%.	$97	$1,762	$394
Totals for September:	$1,251	$14,765	$394
Portfolio value at September 19 is $19,012*, up +90.1%. The NASDAQ average for the year so far is up +39.5%